… In conclusion, we can confirm that DHAP in combination with rituximab is effective and feasible
as salvage therapy before HDT/ASCT showing adequate response rates with acceptable …

… The combination of pixantrone and rituximab is currently … chemotherapy are treated as
those with relapsed/refractory … NHL, pixantrone has been shown to be very active, with a …

… care for most patients with untreated or relapsed/refractory DLBCL … the standard of care to
combine rituximab with second or … the United States (Rituxan) will expire in 2018. Furthermore, …

… Rituximab is indicated for treatment of patients with … with R/R FL, in combination with
chemotherapy regimens containing … include rituximab alone or in combination with chemotherapy, …

… rituximab-based regimens in the management of diffuse large B-cell lymphoma (DLBCL), the
high incidence of relapsed/refractory … and the combination of rituximab with chemotherapy, …

… This article reviews alternative combination conditioning regimens, as well as novel … DLBCL
were randomized to salvage chemotherapy with R‐ICE (rituximab, Ifosfamide, carboplatin, …

… in patients with relapsed/refractory lymphoma. This was a … is seen with conventional
chemotherapy drugs. Patients who … of drugs highly active in PTCL can be combined safely with a …

… 2 lines of systemic therapy that includes Rituxan® and one … therapy with highdose
chemotherapy with stem cell rescue, high-… ciloleucel in subjects with relapsed/refractory indolent …

… -chemotherapy, including combination chemotherapy, most … a combination of rituximab
and epratuzumab (NCT00301821… In CheckMate 039, trial patients with relapsed/refractory …

… inhibitor active in DLBCL, including DHL, and its combination … chemotherapy regimen for
DLBCL is R-CHOP (rituximab, … of patients with new or relapsed/refractory multiple myeloma [9]. …